CUE

Cue Biopharma, Inc.

$13.26-4.67 (-26.05%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Cue Biopharma, Inc. (CUE) is a publicly traded company with 3 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.

Latest Insider Transactions

Showing 10 of 20 transactions (past 365 days)

CUE
SVP
Award
$58K
Sandercock Colin200,000 shares @ $0.29
Filed 2026-04-10Trade 2026-04-09
CUE
CBO
Award
$72.5K
Warren Lucinda250,000 shares @ $0.29
Filed 2026-04-10Trade 2026-04-09
CUE
CDO
Award
$29K
Baker Daniel G.100,000 shares @ $0.29
Filed 2026-04-10Trade 2026-04-09
CUE
Director
Award
$0
Garzone Pamela24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Award
$0
Sarraf Pasha24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Award
$0
Kiener Peter A24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Award
$0
Broadfoot Jill Marie24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Award
$0
Verheyen Patrick24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Award
$0
Morich Frank24,400 shares @ $0.00
Filed 2026-01-06Trade 2026-01-02
CUE
Director
Purchase
$23.1K
Sarraf Pasha77,148 shares @ $0.30
Filed 2026-01-02Trade 2025-12-30

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →